Ibrance 75 mg/1

Ibrance 75 mg is a prescription medication used in the treatment of certain types of cancer. This film-coated tablet is manufactured by Pfizer Laboratories and is taken orally.

Ibrance 75 mg is primarily used in combination with other medications for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer. It works by helping to slow down the progression of cancer cells. Patients often wonder, 'What is Ibrance used for?' and the answer is that it is typically prescribed for specific types of breast cancer in postmenopausal women or in combination with other treatments.

Common effects of Ibrance 75 mg may include fatigue, nausea, hair loss, and diarrhea. Some patients may also experience infections, low blood cell counts, and changes in appetite. It is important to discuss any persistent or severe side effects with a healthcare provider.

Ibrance 75 mg should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid crushing or breaking the tablets unless instructed to do so. Pregnant women or those planning to become pregnant should consult their doctor before taking this medication.

Ibrance 75 mg may interact with certain medications, including strong CYP3A inhibitors and inducers. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Ibrance, so it is advisable to discuss any concerns with a healthcare professional.